Skip to main content
Clinical Trials/JPRN-UMIN000042203
JPRN-UMIN000042203
Completed
未知

Investigation of factors affecting patients' preference of biologics treatment modes with rheumatoid arthritis - Investigation of factors affecting patients' preference of biologics treatment modes with rheumatoid arthritis

Mitsubishi Tanabe Pharma Corporation0 sites400 target enrollmentOctober 22, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
rheumatoid arthritis
Sponsor
Mitsubishi Tanabe Pharma Corporation
Enrollment
400
Status
Completed
Last Updated
2 years ago